Earnings Feed
Start Free
Home/Filings/4/0001209191-15-040802
4//SEC Filing

HYPERION THERAPEUTICS INC 4

Accession 0001209191-15-040802

CIK 0001386858operating
View on SEC.govCompany Profile

Filed

May 7, 8:00 PM ET

Accepted

May 8, 7:47 PM ET

Size

21.6 KB

Accession

0001209191-15-040802

Insider Transaction Report

Form 4
Period: 2015-05-07
HYPERION THERAPEUTICS INCHPTX
Nash Christine A
SVP & Chief Commercial Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2015-05-07$46.00/sh−59,087$2,718,002→ 0 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07−18→ 0 total
    Exercise: $327.95Exp: 2018-04-21→ Common Stock (18 underlying)
  • Disposition from Tender

    Common Stock

    2015-05-07$46.00/sh−11,503$529,138→ 0 total
  • Disposition to Issuer

    Common Stock

    2015-05-07$46.00/sh−25,500$1,173,000→ 0 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−50,000$2,300,000→ 0 total
    Exercise: $26.74Exp: 2024-03-10→ Common Stock (50,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−32,500$1,495,000→ 0 total
    Exercise: $25.97Exp: 2025-02-08→ Common Stock (32,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07−91→ 0 total
    Exercise: $327.95Exp: 2017-08-30→ Common Stock (91 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−6,881$316,526→ 0 total
    Exercise: $7.31Exp: 2022-04-15→ Common Stock (6,881 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-07$46.00/sh−39,500$1,817,000→ 0 total
    Exercise: $24.46Exp: 2023-04-14→ Common Stock (39,500 underlying)
Footnotes (5)
  • [F1]Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer.
  • [F2]Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger").
  • [F3]Shares that are being acquired by Horizon in the Merger.
  • [F4]Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.
  • [F5]Options to acquire shares of issuer common stock that will be cancelled for no consideration in connection with the Merger.

Documents

1 file

Issuer

HYPERION THERAPEUTICS INC

CIK 0001386858

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001386858

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 7:47 PM ET
Size
21.6 KB
View on SEC.gov